Scientists test how common antibiotic affects prostate cancer drug
NCT ID NCT07014488
Summary
This study tested how an antibiotic called rifampicin affects the way the body processes an experimental prostate cancer drug called HRS-5041. Researchers gave both drugs to 16 healthy male volunteers to measure drug levels in their blood. The goal was to understand potential drug interactions that could affect dosing if patients need both medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)
Jinan, Shandong, 250014, China
Conditions
Explore the condition pages connected to this study.